Alpha-phenylacetoacetonitrile 分子结构式
HCID20547

Alpha-phenylacetoacetonitrile

3-oxo-2-phenylbutanenitrile

C10H9NO159.18 g/molCAS 4468-48-8

IDENTITY

结构与身份

标准SMILES
CC(=O)C(C#N)c1ccccc1
InChIKey
KHNWFTMUBKJWRZ-UHFFFAOYSA-N
分子式
C10H9NO
平均分子量
159.18 g/mol
单同位素质量
159.06841391

COMPUTED

结构计算性质

已同步
XLogP
1.5
极性表面积
40.9 Ų
氢键供体
0
氢键受体
2
可旋转键
2
重原子
12
形式电荷
0
复杂度
207

GHS

GHS分类

来源:PubChem
GHS Classification

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral];H312 (100%): Harmful in contact with skin [Warning Acute toxicity, dermal];H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation];H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation];H332 (100%): Harmful if inhaled [Warning Acute toxicity, inhalation];H335 (100%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]

P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P317, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 42 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.

HAZARDS

危害信息

来源:PubChem
Regulatory Information

List I Chemical: A chemical specified by regulation that, in addition to legitimate uses, is used in manufacturing a controlled substance in violation of the Act and is important to the manufacture of a controlled substance. (21 eCFR 1310.02)

Hazard Classes and Categories

Acute Tox. 4 (100%);Acute Tox. 4 (100%);Skin Irrit. 2 (100%);Eye Irrit. 2 (100%);Acute Tox. 4 (100%);STOT SE 3 (100%)

REGULATORY

法规信息

来源:PubChem
Regulatory Information

List I Chemical: A chemical specified by regulation that, in addition to legitimate uses, is used in manufacturing a controlled substance in violation of the Act and is important to the manufacture of a controlled substance. (21 eCFR 1310.02)

USES

用途与制造

来源:PubChem
DEA Listed Chemicals

Alpha-phenylacetoacetonitrile and its salts, optical isomers, and salts of optical isomers (APAAN)

A chemical specified by regulation that, in addition to legitimate uses, is used in manufacturing a controlled substance in violation of the Act and is important to the manufacture of a controlled substance. (21 eCFR 1310.02)

General Manufacturing Information

Benzeneacetonitrile, .alpha.-acetyl-: INACTIVE

ALIASES

名称与别名

共 78 条
alpha-PhenylacetoacetonitrileRefChem:1110722-Phenylacetoacetonitrile4468-48-83-Oxo-2-phenylbutanenitrilealpha-AcetylphenylacetonitrileAcetonitrile, phenylacetoUSAF PE-1Acetoacetonitrile, 2-phenyl-a-acetylphenylacetonitrile1-Cyano-1-phenyl-2-propanoneBenzeneacetonitrile, alpha-acetyl-120065-76-12-Acetyl-2-phenylacetonitrileNSC 25183ACETONITRILE, 2-ACETYL-2-PHENYL-Benzeneacetonitrile, .alpha.-acetyl-NSC 11777NSC 55206.alpha.-Phenylacetoacetonitrile

REACTIONS

参与反应

8
HRID 30361 反应方程式

uspto-grants-2008_09 · 10.6084/m9.figshare.5104873.v1 · US07423067B2

查看
HRID 293771 反应方程式

Training data from https://doi.org/10.1039/C8SC04228D (8/10) · 10.1039/C8SC04228D

查看
HRID 801306 反应方程式

Test data from https://doi.org/10.1039/C8SC04228D · 10.1039/C8SC04228D

查看
HRID 1394570 反应方程式

uspto-grants-2008_03 · 10.6084/m9.figshare.5104873.v1 · US07348456B2

查看
HRID 1446391 反应方程式

uspto-grants-2010_02 · 10.6084/m9.figshare.5104873.v1 · US07667053B2

查看
HRID 1783302 反应方程式

uspto-grants-2009_03 · 10.6084/m9.figshare.5104873.v1 · US07501412B2

查看
HRID 2104289 反应方程式

uspto-grants-2009_08 · 10.6084/m9.figshare.5104873.v1 · US07576239B2

查看
HRID 2109935 反应方程式

uspto-grants-2009_04 · 10.6084/m9.figshare.5104873.v1 · US07517878B2

查看